Mutational analysis of ABC proteins.

The 49 human members of the ATP-binding cassette (ABC) family of proteins are involved in a wide range of activities such as active transport of compounds across membranes, extraction of compounds out of membranes, functioning as ion channels, or regulators of channel activity. Mutations and/or overexpression of many of the proteins can have adverse effects on health. A goal in the study of ABC proteins is to understand their mechanisms of action. This review will focus on the mutational approaches that have been used to study the structure and mechanisms of some ABC proteins.

[1]  S. Cole,et al.  Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1). , 2004, Molecular pharmacology.

[2]  D. Clarke,et al.  Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. , 2006, The Biochemical journal.

[3]  Michael Wiese,et al.  Identification of Putative Binding Sites of P‐glycoprotein Based on its Homology Model , 2008, ChemMedChem.

[4]  A. E. Senior,et al.  Synergy between Conserved ABC Signature Ser Residues in P-glycoprotein Catalysis* , 2004, Journal of Biological Chemistry.

[5]  R. Epstein,et al.  Identification of genes differentially expressed in breast cancer cells treated with tamoxifen, using microarray-based expression profiling , 2001, Nature Genetics.

[6]  Robert Tampé,et al.  The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. , 2004, Physiology.

[7]  J. Riordan,et al.  Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. , 1979, The Journal of biological chemistry.

[8]  D. Clarke,et al.  Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein. , 1993, The Journal of biological chemistry.

[9]  C. Higgins,et al.  Communication between multiple drug binding sites on P-glycoprotein. , 2000, Molecular pharmacology.

[10]  S. Cole,et al.  Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. , 2006, Physiological reviews.

[11]  V. Ling,et al.  Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drug-binding site. , 2001, European journal of biochemistry.

[12]  J. H. Beijnen,et al.  Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.

[13]  A. Safa,et al.  Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators. , 2004, Current medicinal chemistry. Anti-cancer agents.

[14]  H. Omote,et al.  A Novel Electron Paramagnetic Resonance Approach to Determine the Mechanism of Drug Transport by P-glycoprotein* , 2002, The Journal of Biological Chemistry.

[15]  R. Boucher,et al.  Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. , 1992, The Journal of biological chemistry.

[16]  O. Béjà,et al.  Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain. , 1994, The Journal of biological chemistry.

[17]  D. Clarke,et al.  Reconstitution of drug-stimulated ATPase activity following co-expression of each half of human P-glycoprotein as separate polypeptides. , 1994, The Journal of biological chemistry.

[18]  D. Clarke,et al.  Insertion of an Arginine Residue into the Transmembrane Segments Corrects Protein Misfolding* , 2006, Journal of Biological Chemistry.

[19]  D. Clarke,et al.  Substrate-induced Conformational Changes in the Transmembrane Segments of Human P-glycoprotein , 2003, The Journal of Biological Chemistry.

[20]  B. Sikic,et al.  Multidrug-resistant Human Sarcoma Cells with a Mutant P-Glycoprotein, Altered Phenotype, and Resistance to Cyclosporins* , 1997, The Journal of Biological Chemistry.

[21]  D. Tieleman,et al.  Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein. , 2007, Biochemistry.

[22]  D. Clarke,et al.  Defining the Drug-binding Site in the Human Multidrug Resistance P-glycoprotein Using a Methanethiosulfonate Analog of Verapamil, MTS-verapamil* , 2001, The Journal of Biological Chemistry.

[23]  L. Reuss,et al.  Membrane Transport Proteins with Complete Replacement of Transmembrane Helices with Polyalanine Sequences Remain Functional* , 2005, Journal of Biological Chemistry.

[24]  Andrei Aleksandrov,et al.  Domain interdependence in the biosynthetic assembly of CFTR. , 2007, Journal of molecular biology.

[25]  Li-Wei Hung,et al.  Crystal structure of the ATP-binding subunit of an ABC transporter , 1998, Nature.

[26]  D. Clarke,et al.  Covalent Modification of Human P-glycoprotein Mutants Containing a Single Cysteine in Either Nucleotide-binding Fold Abolishes Drug-stimulated ATPase Activity (*) , 1995, The Journal of Biological Chemistry.

[27]  B. Sarkadi,et al.  An inventory of the human ABC proteins. , 1999, Biochimica et biophysica acta.

[28]  P. Gros,et al.  Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3. , 1995, Biochemistry.

[29]  K. Linton,et al.  Repacking of the transmembrane domains of P‐glycoprotein during the transport ATPase cycle , 2001, The EMBO journal.

[30]  H. Rosing,et al.  The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Clarke,et al.  The human multidrug resistance P‐glycoprotein is inactive when its maturation is inhibited: potential for a role in cancer chemotherapy , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  K. Linton,et al.  Evidence for a Sav1866‐like architecture for the human multidrug transporter P‐glycoprotein , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Y. Sugimoto,et al.  Role of Cys‐603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2 , 2005, Cancer science.

[34]  Stephan Wilkens,et al.  Nucleotide-induced Structural Changes in P-glycoprotein Observed by Electron Microscopy* , 2008, Journal of Biological Chemistry.

[35]  T. Elliott,et al.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex , 1992, Nature.

[36]  D. Clarke,et al.  Identification of Residues within the Drug-binding Domain of the Human Multidrug Resistance P-glycoprotein by Cysteine-scanning Mutagenesis and Reaction with Dibromobimane* , 2000, The Journal of Biological Chemistry.

[37]  J. Riordan,et al.  ATP Binding to the First Nucleotide Binding Domain of Multidrug Resistance-associated Protein Plays a Regulatory Role at Low Nucleotide Concentration, whereas ATP Hydrolysis at the Second Plays a Dominant Role in ATP-dependent Leukotriene C4 Transport* , 2003, Journal of Biological Chemistry.

[38]  Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel , 1991, Cell.

[39]  M. Welsh,et al.  Association of domains within the cystic fibrosis transmembrane conductance regulator. , 1997, Biochemistry.

[40]  K. Locher,et al.  Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.

[41]  K. Linton,et al.  An atomic detail model for the human ATP binding cassette transporter P‐glycoprotein derived from disulphide cross‐ linking and homology modeling , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Is arginine charged in a membrane? , 2008, Biophysical journal.

[43]  D. Clarke,et al.  Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein* , 2002, The Journal of Biological Chemistry.

[44]  A. Ravna,et al.  Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5) , 2007, Theoretical Biology & Medical Modelling.

[45]  F. Sharom,et al.  Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle. , 2003, Biochemistry.

[46]  A. Davidson,et al.  Vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  D. Clarke,et al.  The “LSGGQ” Motif in Each Nucleotide-binding Domain of Human P-glycoprotein Is Adjacent to the Opposing Walker A Sequence* , 2002, The Journal of Biological Chemistry.

[48]  D. Clarke,et al.  Methanethiosulfonate Derivatives of Rhodamine and Verapamil Activate Human P-glycoprotein at Different Sites* , 2003, Journal of Biological Chemistry.

[49]  D. Clarke,et al.  Permanent Activation of the Human P-glycoprotein by Covalent Modification of a Residue in the Drug-binding Site* , 2003, Journal of Biological Chemistry.

[50]  D. Clarke,et al.  Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Schellens,et al.  Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. , 2000, Journal of the National Cancer Institute.

[52]  Matthew P. Anderson,et al.  Effect of deleting the R domain on CFTR-generated chloride channels. , 1991, Science.

[53]  D. Clarke,et al.  Suppressor Mutations in the Transmembrane Segments of P-glycoprotein Promote Maturation of Processing Mutants and Disrupt a Subset of Drug-binding Sites* , 2007, Journal of Biological Chemistry.

[54]  D. Clarke,et al.  Drug-stimulated ATPase Activity of Human P-glycoprotein Requires Movement between Transmembrane Segments 6 and 12* , 1997, The Journal of Biological Chemistry.

[55]  D. Clarke,et al.  Modulating the Folding of P-Glycoprotein and Cystic Fibrosis Transmembrane Conductance Regulator Truncation Mutants with Pharmacological Chaperones , 2007, Molecular Pharmacology.

[56]  K. Locher,et al.  Structure of an ABC transporter in complex with its binding protein , 2007, Nature.

[57]  D. Clarke,et al.  Inhibition of Oxidative Cross-linking between Engineered Cysteine Residues at Positions 332 in Predicted Transmembrane Segments (TM) 6 and 975 in Predicted TM12 of Human P-glycoprotein by Drug Substrates* , 1996, The Journal of Biological Chemistry.

[58]  I. Pastan,et al.  A single amino acid residue contributes to distinct mechanisms of inhibition of the human multidrug transporter by stereoisomers of the dopamine receptor antagonist flupentixol. , 1999, Biochemistry.

[59]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[60]  P. Gros,et al.  Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and Immunofluorescence (*) , 1996, The Journal of Biological Chemistry.

[61]  D. Clarke,et al.  Rapid Purification of Human P-glycoprotein Mutants Expressed Transiently in HEK 293 Cells by Nickel-Chelate Chromatography and Characterization of their Drug-stimulated ATPase Activities (*) , 1995, The Journal of Biological Chemistry.

[62]  G. Szakács,et al.  Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain* , 1998, The Journal of Biological Chemistry.

[63]  Ying Wang,et al.  Correctors Promote Maturation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-processing Mutants by Binding to the Protein* , 2007, Journal of Biological Chemistry.

[64]  D. Clarke,et al.  Simultaneous Binding of Two Different Drugs in the Binding Pocket of the Human Multidrug Resistance P-glycoprotein* , 2003, Journal of Biological Chemistry.

[65]  D. Clarke,et al.  P-glycoprotein , 1995, The Journal of Biological Chemistry.

[66]  M. Nakasako,et al.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution , 2000, Nature.

[67]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.

[68]  Jonathan C. Cohen,et al.  ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion* , 2003, Journal of Biological Chemistry.

[69]  T. Litman,et al.  Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. , 2001, Cancer research.

[70]  M. J. van de Vijver,et al.  Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. , 2001, Cancer research.

[71]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[72]  G. Szakács,et al.  Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). , 2000, Journal of cell science.

[73]  K. Nikaido,et al.  Complete nucleotide sequence and identification of membrane components of the histidine transport operon of S. typhimurium , 1982, Nature.

[74]  Jonathan C. Cohen,et al.  Sterol Transfer by ABCG5 and ABCG8 , 2006, Journal of Biological Chemistry.

[75]  D. Clarke,et al.  Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. , 1994, The Journal of biological chemistry.

[76]  D. Clarke,et al.  The ΔF508 Mutation Disrupts Packing of the Transmembrane Segments of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2004, Journal of Biological Chemistry.

[77]  I. J. Evans,et al.  A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria , 1986, Nature.

[78]  John F Hunt,et al.  ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. , 2002, Molecular cell.

[79]  M. Waalkes,et al.  Arsenic Transport by the Human Multidrug Resistance Protein 1 (MRP1/ABCC1) , 2004, Journal of Biological Chemistry.

[80]  D. Clarke,et al.  The Transmembrane Domains of the Human Multidrug Resistance P-glycoprotein Are Sufficient to Mediate Drug Binding and Trafficking to the Cell Surface* , 1999, The Journal of Biological Chemistry.

[81]  S. Cole,et al.  Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. , 2005, Toxicology and applied pharmacology.

[82]  K. Linton,et al.  The ATP switch model for ABC transporters , 2004, Nature Structural &Molecular Biology.

[83]  K. Danø.  Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. , 1973, Biochimica et biophysica acta.

[84]  D. Clarke,et al.  Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux , 2005, The Journal of Membrane Biology.

[85]  A. E. Senior,et al.  Combined Mutation of Catalytic Glutamate Residues in the Two Nucleotide Binding Domains of P-glycoprotein Generates a Conformation That Binds ATP and ADP Tightly* , 2004, Journal of Biological Chemistry.

[86]  R. Tampé,et al.  Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells , 1994, FEBS letters.

[87]  J. Riordan,et al.  The non‐hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating , 2000, The Journal of physiology.

[88]  R. Dawson,et al.  Structure and mechanism of ABC transporter proteins. , 2007, Current opinion in structural biology.

[89]  D. Clarke,et al.  Drug Binding in Human P-glycoprotein Causes Conformational Changes in Both Nucleotide-binding Domains* , 2003, The Journal of Biological Chemistry.

[90]  R. Tampé,et al.  Mechanism of Substrate Sensing and Signal Transmission within an ABC Transporter , 2006, Journal of Biological Chemistry.

[91]  Peter Cresswell,et al.  Mechanisms of MHC class I‐restricted antigen processing and cross‐presentation , 2005, Immunological reviews.

[92]  D. Clarke,et al.  Superfolding of the Partially Unfolded Core-glycosylated Intermediate of Human P-glycoprotein into the Mature Enzyme Is Promoted by Substrate-induced Transmembrane Domain Interactions* , 1998, The Journal of Biological Chemistry.

[93]  F. Sharom,et al.  Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. , 1996, Biochemistry.

[94]  M. Welsh,et al.  Effect of deletion mutations on the function of CFTR chloride channels. , 1993, Receptors & channels.

[95]  Z. Sauna,et al.  Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  S. Kane,et al.  Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. , 1997, Biochemistry.

[97]  D D Breimer,et al.  Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.

[98]  D. Clarke,et al.  Determining the Dimensions of the Drug-binding Domain of Human P-glycoprotein Using Thiol Cross-linking Compounds as Molecular Rulers* , 2001, The Journal of Biological Chemistry.

[99]  M C Willingham,et al.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[100]  W. T. Beck,et al.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. , 1979, Cancer research.

[101]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[102]  A. Bhatia,et al.  Oligomerization of the human ABC transporter ABCG2: evaluation of the native protein and chimeric dimers. , 2005, Biochemistry.

[103]  A. E. Senior,et al.  Covalent inhibitors of P-glycoprotein ATPase activity. , 1994, The Journal of biological chemistry.

[104]  D. Rees,et al.  An Inward-Facing Conformation of a Putative Metal-Chelate-Type ABC Transporter , 2007, Science.

[105]  Karl Kuchler,et al.  ABC proteins : from bacteria to man , 2003 .

[106]  M. Prévost,et al.  Predicting the three‐dimensional structure of human P‐glycoprotein in absence of ATP by computational techniques embodying crosslinking data: Insight into the mechanism of ligand migration and binding sites , 2006, Proteins.

[107]  K. Linton,et al.  Structure and function of ABC transporters: the ATP switch provides flexible control , 2007, Pflügers Archiv - European Journal of Physiology.

[108]  D. Clarke,et al.  Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators* , 1997, The Journal of Biological Chemistry.

[109]  D. Clarke,et al.  The drug-binding pocket of the human multidrug resistance P-glycoprotein is accessible to the aqueous medium. , 2004, Biochemistry.

[110]  D. Clarke,et al.  ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein. , 2005, Biochemistry.

[111]  Z. Sauna,et al.  Exploiting Reaction Intermediates of the ATPase Reaction to Elucidate the Mechanism of Transport by P-glycoprotein (ABCB1)* , 2006, Journal of Biological Chemistry.

[112]  Stephan Kopp,et al.  P-Glycoprotein Substrate Binding Domains Are Located at the Transmembrane Domain/Transmembrane Domain Interfaces: A Combined Photoaffinity Labeling-Protein Homology Modeling Approach , 2005, Molecular Pharmacology.

[113]  T. Janvilisri,et al.  Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2). , 2005, The Biochemical journal.

[114]  D. Clarke,et al.  The Minimum Functional Unit of Human P-glycoprotein Appears to be a Monomer* , 1996, The Journal of Biological Chemistry.

[115]  H. A. Berger,et al.  Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. , 1991, The Journal of clinical investigation.

[116]  Angus C Nairn,et al.  In vivo phosphorylation of CFTR promotes formation of a nucleotide‐binding domain heterodimer , 2006, The EMBO journal.

[117]  John A. Tainer,et al.  Structural Biology of Rad50 ATPase ATP-Driven Conformational Control in DNA Double-Strand Break Repair and the ABC-ATPase Superfamily , 2000, Cell.

[118]  J. Schuetz,et al.  Role of ABCG2/BCRP in biology and medicine. , 2006, Annual review of pharmacology and toxicology.

[119]  F. Sharom,et al.  Proximity of bound Hoechst 33342 to the ATPase catalytic sites places the drug binding site of P-glycoprotein within the cytoplasmic membrane leaflet. , 2002, Biochemistry.

[120]  Anand K. Srivastava,et al.  Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption , 2001, Nature Genetics.

[121]  I. Pastan,et al.  Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[122]  S. Devine,et al.  Amino acid substitutions in the sixth transmembrane domain of P-glycoprotein alter multidrug resistance. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Stephan Kopp,et al.  Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP. , 2007, Biochemistry.

[124]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[125]  D. Clarke,et al.  Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"? , 2005, Biochemical and biophysical research communications.

[126]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[127]  N. Grishin,et al.  Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. , 2000, Science.

[128]  D. Clarke,et al.  Location of high affinity Ca2 +-binding sites within the predicted transmembrahe domain of the sarco-plasmic reticulum Ca2+-ATPase , 1989, Nature.

[129]  D. Clarke,et al.  Chemical and pharmacological chaperones as new therapeutic agents , 2007, Expert Reviews in Molecular Medicine.

[130]  Douglas C. Rees,et al.  The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.

[131]  K. Kuchler,et al.  Intracellular location, complex formation, and function of the transporter associated with antigen processing in yeast. , 1997, European journal of biochemistry.

[132]  S. Cole,et al.  Charged Amino Acids in the Sixth Transmembrane Helix of Multidrug Resistance Protein 1 (MRP1/ABCC1) Are Critical Determinants of Transport Activity* , 2002, The Journal of Biological Chemistry.

[133]  I. Pastan,et al.  Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. , 1992, The Journal of biological chemistry.

[134]  D. Clarke,et al.  Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. , 1994, Biochemistry.

[135]  Eitan Bibi,et al.  Multidrug Resistance Protein (Mdr)-alkaline Phosphatase Hybrids in Escherichia coli Suggest a Major Revision in the Topology of the C-terminal Half of Mdr (*) , 1995, The Journal of Biological Chemistry.

[136]  D. Clarke,et al.  Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments. , 2007, Biochemistry.

[137]  C. Higgins,et al.  The homodimeric ATP‐binding cassette transporter LmrA mediates multidrug transport by an alternating two‐site (two‐cylinder engine) mechanism , 2000, The EMBO journal.

[138]  R. Callaghan,et al.  The coupling mechanism of P‐glycoprotein involves residue L339 in the sixth membrane spanning segment , 2005, FEBS letters.

[139]  I. Pastan,et al.  Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.

[140]  V. Lingappa,et al.  Evidence for an alternate model of human P-glycoprotein structure and biogenesis. , 1993, The Journal of biological chemistry.

[141]  D. Clarke,et al.  Transmembrane segment 1 of human P-glycoprotein contributes to the drug-binding pocket. , 2006, The Biochemical journal.

[142]  Stephan Kopp,et al.  Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. , 2002, Molecular pharmacology.

[143]  Milan Macek,et al.  Cystic fibrosis: A worldwide analysis of CFTR mutations—correlation with incidence data and application to screening , 2002, Human mutation.

[144]  S. Cole,et al.  Transport of glutathione and glutathione conjugates by MRP1. , 2006, Trends in pharmacological sciences.

[145]  Lutz Schmitt,et al.  H662 is the linchpin of ATP hydrolysis in the nucleotide‐binding domain of the ABC transporter HlyB , 2005, The EMBO journal.

[146]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[147]  D. Tieleman,et al.  P‐glycoprotein models of the apo and ATP‐bound states based on homology with Sav1866 and MalK , 2007, FEBS letters.

[148]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[149]  D. Clarke,et al.  Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[150]  D. Clarke,et al.  Identification of Residues in the Drug-binding Site of Human P-glycoprotein Using a Thiol-reactive Substrate* , 1997, The Journal of Biological Chemistry.

[151]  F. Sharom,et al.  ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. , 1992, Biochimica et biophysica acta.

[152]  M. R. Lugo,et al.  Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site. , 2005, Biochemistry.

[153]  V. Ling,et al.  Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. , 1997, European journal of biochemistry.

[154]  D. Clarke,et al.  Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.

[155]  P. Hafkemeyer,et al.  Allosteric Modulation of Human P-glycoprotein , 2003, The Journal of Biological Chemistry.

[156]  D. Clarke,et al.  Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.

[157]  L. Heppel,et al.  Different mechanisms of energy coupling for the shock-sensitive and shock-resistant amino acid permeases of Escherichia coli. , 1974, The Journal of biological chemistry.

[158]  D. Clarke,et al.  Identification of Residues in the Drug-binding Domain of Human P-glycoprotein , 1999, The Journal of Biological Chemistry.

[159]  C. Higgins,et al.  The vinblastine binding site adopts high- and low-affinity conformations during a transport cycle of P-glycoprotein. , 2001, Biochemistry.

[160]  K. Linton,et al.  The Topography of Transmembrane Segment Six Is Altered during the Catalytic Cycle of P-glycoprotein* , 2004, Journal of Biological Chemistry.

[161]  J. Blalock,et al.  CFTR chloride channel regulation by an interdomain interaction. , 1999, Science.

[162]  D. Clarke,et al.  Cross-linking of Human Multidrug Resistance P-glycoprotein by the Substrate, Tris-(2-maleimidoethyl)amine, Is Altered by ATP Hydrolysis , 2001, The Journal of Biological Chemistry.

[163]  D. Gadsby,et al.  ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. , 1997, Seminars in cancer biology.

[164]  I. Pastan,et al.  Deletion and insertion mutants of the multidrug transporter. , 1989, The Journal of biological chemistry.

[165]  E. Gilson,et al.  Extensive homology between membrane-associated components of histidine and maltose transport systems of Salmonella typhimurium and Escherichia coli. , 1982, The Journal of biological chemistry.

[166]  T. Tsuruo,et al.  Dominant‐negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S‐S dependent homodimerization , 2002, International journal of cancer.

[167]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[168]  D. Clarke,et al.  The Packing of the Transmembrane Segments of Human Multidrug Resistance P-glycoprotein Is Revealed by Disulfide Cross-linking Analysis* , 2000, The Journal of Biological Chemistry.

[169]  M. R. Lugo,et al.  Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs. , 2005, Biochemistry.

[170]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[171]  J. Endicott,et al.  Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance , 1986, Nature.

[172]  K. Diederichs,et al.  Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis , 2000, The EMBO journal.